AbbVie Inc.ABBVNYSE
Loading
Cost of Revenue Over TimeContracting
Percentile Rank64
3Y CAGR-17.0%
5Y CAGR-8.3%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-17.0%/yr
vs +22.6%/yr prior
5Y CAGR
-8.3%/yr
Recent deceleration
Acceleration
-39.5pp
Decelerating
Percentile
P64
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $9.96B | -41.0% |
| 2024 | $16.90B | -17.2% |
| 2023 | $20.41B | +17.2% |
| 2022 | $17.41B | -0.2% |
| 2021 | $17.45B | +13.4% |
| 2020 | $15.39B | +106.8% |
| 2019 | $7.44B | -3.6% |
| 2018 | $7.72B | +9.6% |
| 2017 | $7.04B | +20.7% |
| 2016 | $5.83B | - |